Similar articles for PMID: 31189699

1

Cite

Share

Planning for Outcomes (P₄O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix.

Lebetkin E, Gao X, Taylor D, Maldonado LY, Saad A, Steiner MJ, Dorflinger LJ, Nanda K, Mastro TD. Lebetkin E, et al. Glob Health Sci Pract. 2019 Jun 27;7(2):317-328. doi: 10.9745/GHSP-D-19-00062. Print 2019 Jun. Glob Health Sci Pract. 2019. PMID: 31189699 Free PMC article.

Cite

Share

2

Cite

Share

Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.

Rodriguez MI, Gaffield ME, Han L, Caughey AB. Rodriguez MI, et al. Glob Health Sci Pract. 2017 Dec 28;5(4):581-591. doi: 10.9745/GHSP-D-17-00243. Print 2017 Dec 28. Glob Health Sci Pract. 2017. PMID: 29284696 Free PMC article.

Cite

Share

3

Cite

Share

Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.

Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, Bowman BA, Olson GS, Mabhula A, Leslie A, Ndung'u T, Walker BD, Ghebremichael MS, Dong KL, Kwon DS. Byrne EH, et al. Lancet Infect Dis. 2016 Apr;16(4):441-8. doi: 10.1016/S1473-3099(15)00429-6. Epub 2015 Dec 24. Lancet Infect Dis. 2016. PMID: 26723758 Free PMC article.

Cite

Share

4

Cite

Share

[Current status of the female condom in Africa].

Deniaud F. Deniaud F. Sante. 1997 Nov-Dec;7(6):405-15. Sante. 1997. PMID: 9503499 Free article. Review. French.

Cite

Share

5

Cite

Share

Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.

Smith JA, Beacroft L, Abdullah F, Buthelezi B, Makua M, Morroni C, Ramjee G, Velasquez C, Hallett TB. Smith JA, et al. J Int AIDS Soc. 2020 Oct;23(10):e25620. doi: 10.1002/jia2.25620. J Int AIDS Soc. 2020. PMID: 33030312 Free PMC article.

Cite

Share

6

Cite

Share

Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.

Hofmeyr GJ, Singata-Madliki M, Lawrie TA, Bergel E, Temmerman M. Hofmeyr GJ, et al. Reprod Health. 2016 Apr 18;13:42. doi: 10.1186/s12978-016-0153-9. Reprod Health. 2016. PMID: 27091008 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.

Jain AK. Jain AK. Contraception. 2012 Dec;86(6):645-52. doi: 10.1016/j.contraception.2012.03.008. Epub 2012 Apr 26. Contraception. 2012. PMID: 22541635 Free article.

Cite

Share

8

Cite

Share

Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.

Patel RC, Morroni C, Scarsi KK, Sripipatana T, Kiarie J, Cohen CR. Patel RC, et al. J Int AIDS Soc. 2017 May 11;20(1):21396. doi: 10.7448/IAS.20.1.21396. J Int AIDS Soc. 2017. PMID: 28530033 Free PMC article. Review.

Cite

Share

9

Cite

Share

Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.

Caplan MR, Landovitz RJ, Palanee-Phillips T, Nair G, Mhlanga F, Balkus JE, Riddler SA, Gorbach PM. Caplan MR, et al. AIDS Care. 2019 Jun;31(6):746-753. doi: 10.1080/09540121.2019.1580345. Epub 2019 Feb 13. AIDS Care. 2019. PMID: 30759997 Free PMC article.

Cite

Share

10

Cite

Share

Reproductive health and family planning needs among HIV-infected women in Sub-Saharan Africa.

Sarnquist CC, Rahangdale L, Maldonado Y. Sarnquist CC, et al. Curr HIV Res. 2013 Mar;11(2):160-8. doi: 10.2174/1570162x11311020008. Curr HIV Res. 2013. PMID: 23432491 Review.

Cite

Share